N-HETEROCYCLIC FIVE-MEMBERED RING-CONTAINING CAPSID PROTEIN ASSEMBLY INHIBITOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF
申请人:Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
公开号:EP3778569A1
公开(公告)日:2021-02-17
A N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, and a pharmaceutical composition and use thereof, specifically relating to a compound as represented by formula I, a stereoisomer, a tautomer, a geometrical isomer, a solvate, an active metabolite, a hydrate, a prodrug or a pharmaceutically acceptable salt thereof, a pharmaceutical composition thereof, and a medical use thereof. The medical use comprises the use in treating diseases benefiting from the capsid protein assembly inhibitor, and in particular, diseases caused by hepatitis B virus infection.
一种含N-杂环五元环的噬菌体蛋白组装抑制剂及其药物组合物和用途,具体涉及一种由式I表示的化合物、其立体异构体、同分异构体、几何异构体、溶解物、活性代谢物、水合物、原药或药学上可接受的盐、其药物组合物及其医疗用途。医疗用途包括用于治疗受益于噬菌体蛋白组装抑制剂的疾病,特别是乙型肝炎病毒感染引起的疾病。